FDA grants full approval to Pfizer Covid treatment Paxlovid for high-risk adults

FDA grants full approval to Pfizer Covid treatment Paxlovid for high-risk adults

Source: 
CNBC
snippet: 

The Food and Drug Administration granted full approval to Pfizer’s Covid antiviral pill Paxlovid for adults who are at high risk of getting severely sick with the virus.